TY - JOUR
T1 - Single-fraction flattening filter-free volumetric modulated arc therapy for lung cancer
T2 - Dosimetric results and comparison with flattened beams technique
AU - Barbiero, Sara
AU - Rink, Alexandra
AU - Matteucci, Fabrizio
AU - Fedele, David
AU - Paiar, Fabiola
AU - Pasqualetti, Francesco
AU - Avanzo, Michele
PY - 2016
Y1 - 2016
N2 - Purpose: To report on single-fraction stereotactic body radiotherapy (RT) (SBRT) with flattening filter (FF)-free (FFF) volumetric modulated arc therapy (VMAT) for lung cancer and to compare dosimetric results with VMAT with FF. Methods and materials: Overall, 25 patients were treated with 6-MV FFF VMAT (Varian TrueBeam STx LINAC) to a prescribed dose of 24. Gy in a single fraction. Treatment plans were recreated using FF VMAT. Dose-volume indices, monitor units (MU), and treatment times were compared between FFF and FF VMAT techniques. Results: Dose constraints to PTV, spinal cord, and lungs were reached in FFF and FF plans. In FFF plans, average conformity index was 1.13 (95% CI: 1.07 to1.38). Maximum doses to spinal cord, heart, esophagus, and trachea were 2.9. Gy (95% CI: 0.4 to 6.7. Gy), 0.8. Gy (95% CI: 0 to 3.6. Gy), 3.3. Gy (95% CI: 0.02 to 13.9. Gy), and 1.5. Gy (95% CI: 0 to 4.9. Gy), respectively. Average V7. Gy, V7.4. Gy, and mean dose to the healthy lung were 126.5. cc (95% CI: 41.3 to 248.9. cc), 107.3. cc (95% CI: 18.7 to 232.8. cc), and 1.1. Gy (95% CI: 0.3 to 2.2. Gy), respectively. No statistically significant differences were found in dosimetric results and MU between FF and FFF treatments. Treatment time was reduced by an average factor of 2.31 (95% CI: 2.15 to 2.43) from FF treatments to FFF, and the difference was statistically significant. Conclusions: FFF VMAT for lung SBRT provides equivalent dosimetric results to the target and organs at risk as FF VMAT while significantly reducing treatment time.
AB - Purpose: To report on single-fraction stereotactic body radiotherapy (RT) (SBRT) with flattening filter (FF)-free (FFF) volumetric modulated arc therapy (VMAT) for lung cancer and to compare dosimetric results with VMAT with FF. Methods and materials: Overall, 25 patients were treated with 6-MV FFF VMAT (Varian TrueBeam STx LINAC) to a prescribed dose of 24. Gy in a single fraction. Treatment plans were recreated using FF VMAT. Dose-volume indices, monitor units (MU), and treatment times were compared between FFF and FF VMAT techniques. Results: Dose constraints to PTV, spinal cord, and lungs were reached in FFF and FF plans. In FFF plans, average conformity index was 1.13 (95% CI: 1.07 to1.38). Maximum doses to spinal cord, heart, esophagus, and trachea were 2.9. Gy (95% CI: 0.4 to 6.7. Gy), 0.8. Gy (95% CI: 0 to 3.6. Gy), 3.3. Gy (95% CI: 0.02 to 13.9. Gy), and 1.5. Gy (95% CI: 0 to 4.9. Gy), respectively. Average V7. Gy, V7.4. Gy, and mean dose to the healthy lung were 126.5. cc (95% CI: 41.3 to 248.9. cc), 107.3. cc (95% CI: 18.7 to 232.8. cc), and 1.1. Gy (95% CI: 0.3 to 2.2. Gy), respectively. No statistically significant differences were found in dosimetric results and MU between FF and FFF treatments. Treatment time was reduced by an average factor of 2.31 (95% CI: 2.15 to 2.43) from FF treatments to FFF, and the difference was statistically significant. Conclusions: FFF VMAT for lung SBRT provides equivalent dosimetric results to the target and organs at risk as FF VMAT while significantly reducing treatment time.
KW - Conformity index
KW - Dose volume
KW - Flattening filter free
KW - Homogeneity
KW - Lung cancer
KW - VMAT
UR - http://www.scopus.com/inward/record.url?scp=84991267486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991267486&partnerID=8YFLogxK
U2 - 10.1016/j.meddos.2016.09.002
DO - 10.1016/j.meddos.2016.09.002
M3 - Article
AN - SCOPUS:84991267486
SP - 334
EP - 338
JO - Medical Dosimetry
JF - Medical Dosimetry
SN - 0958-3947
ER -